INTRODUCTION: Sepsis is the main cause of morbidity and mortality in intensive care units and its early diagnosis is not straightforward. Many studies have evaluated the usefulness of various markers of infection, including C-reactive protein (CRP), which is the most accessible and widely used. CRP is of weak diagnostic value because of its low specificity; a better understanding of patterns of CRP levels associated with a particular form of infection may improve its usefulness as a sepsis marker. In the present article, we apply multilevel modeling techniques and mixed linear models to CRP-related data to assess the time course of CRP blood levels in association with clinical outcome in children with different septic conditions. METHODS: We performed a retrospective analysis of 99 patients with systemic inflammatory response syndrome, sepsis, or septic shock who were admitted to the Pediatric Critical Care Unit at the University Hospital, Brno. CRP blood levels were monitored for 10 days following the onset of the septic condition. The effect of different septic conditions and of the surgical or nonsurgical diagnosis on CRP blood levels was statistically analyzed using mixed linear models with a multilevel modeling approach. RESULTS: A significant effect of septic condition and diagnosis on the course of CRP levels was identified. In patients who did not progress to septic shock, CRP blood levels decreased rapidly after reaching peak values - in contrast to the values in patients with septic shock in whom CRP protein levels decreased slowly. Moreover, CRP levels in patients with a surgical diagnosis were higher than in patients with a nonsurgical condition. The magnitude of this additional elevation in surgical patients did not depend on the septic condition. CONCLUSION: Understanding the pattern of change in levels of CRP associated with a particular condition may improve its diagnostic and prognostic value in children with sepsis.

1st Department of Pediatrics University Hospital Brno Cernopolni 9 Brno 61300 Czech Republic

Crit Care. 2007;11(4):152. doi: 10.1186/cc5968. PubMed

Zobrazit více v PubMed

Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest. 1996;109:1033–1037. PubMed

Carvalho PR, Feldens L, Seitz EE, Rocha TS, Soledade MA, Trotta EA. Prevalence of systemic inflammatory syndromes at a tertiary pediatric intensive care unit. J Pediatr (Rio J) 2005;81:143–148. PubMed

Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31:170–176. doi: 10.1086/313925. PubMed DOI

Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–766. doi: 10.1128/AAC.49.2.760-766.2005. PubMed DOI PMC

BalcI C, Sungurtekin H, Gurses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003;7:85–90. doi: 10.1186/cc1843. PubMed DOI PMC

Fida NM, Al-Mughales J, Farouq M. Interleukin-1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr Int. 2006;48:118–124. doi: 10.1111/j.1442-200X.2006.02152.x. PubMed DOI

Du B, Pan J, Chen D, Li Y. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl) 2003;116:538–542. PubMed

Latifi SQ, O'Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun. 2002;70:4441–4446. doi: 10.1128/IAI.70.8.4441-4446.2002. PubMed DOI PMC

Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847] Crit Care. 2004;8:R443–450. doi: 10.1186/cc2971. PubMed DOI PMC

Wyllie DH, Bowler IC, Peto TE. Bacteraemia prediction in emergency medical admissions: role of C reactive protein. J Clin Pathol. 2005;58:352–356. doi: 10.1136/jcp.2004.022293. PubMed DOI PMC

Povoa PE, Almeida P, Moreira A, Fernandes R, Mealha A, Aragao A, Sabino H. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24:1052–1056. doi: 10.1007/s001340050715. PubMed DOI

Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102:E41. doi: 10.1542/peds.102.4.e41. PubMed DOI

Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:234–242. doi: 10.1186/cc2877. PubMed DOI PMC

Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123:2043–2049. doi: 10.1378/chest.123.6.2043. PubMed DOI

Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, Moutardier V, Blache JL. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94:767–773. doi: 10.1093/bja/aei143. PubMed DOI

von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, Schmidt-Wolf IG, Marklein G, Schroeder S, Stuber F. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23:539–544. doi: 10.1007/s10096-004-1156-y. PubMed DOI

Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care. 2006;10:R63. doi: 10.1186/cc4892. PubMed DOI PMC

Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006;10:R1. doi: 10.1186/cc3910. PubMed DOI PMC

Singer JD, Willett JB. Applied Longitudinal Data Analysis. New York: Oxfod University Press; 2003.

Singer JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educat Behav Statist. 1998;24:323–355. doi: 10.2307/1165280. DOI

Hox JJ. Applied Multilevel Analysis. Amsterdam: TT-Publikaties; 1995.

Littell RC, Henry PR, Ammerman CB. Statistical analysis of repeated measures data using SAS procedures. J Anim Sci. 1998;76:1216–1231. PubMed

Michalek J, Svetlikova P, Fedora M, Klimovic M, Klapacova L, Bartosova D, Hrstkova H, Hubacek JA. Bactericidal permeability increasing protein gene variants in children with sepsis. Intensive Care Med. 2007. submitted. PubMed

Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8. doi: 10.1097/01.PCC.0000149131.72248.E6. PubMed DOI

Reith BH, Mittelkotter U, Debus ES, Kussner C, Thiede A. Procalcitonin in early detection of postoperative complications. Dig Surg. 1998;15:260–265. doi: 10.1159/000018625. PubMed DOI

Maruna P, Gurlich R, Frasko R, Chachkhiani I, Marunova M, Owen K, Peskova M. Procalcitonin in the diagnosis of postoperative complications. Sb Lek. 2002;103:283–295. PubMed

Smith JW, Gamelli RL, Jones SB, Shankar R. Immunologic responses to critical injury and sepsis. J Intensive Care Med. 2006;21:160–172. doi: 10.1177/0885066605284330. PubMed DOI

Viedma Contreras JA. Leucocyte activation markers in clinical practice. Clin Chem Lab Med. 1999;37:607–622. doi: 10.1515/CCLM.1999.096. PubMed DOI

Stevens J. Applied Multivariate Statistics for Social Sciences. 2. Hillsdale, NJ: Lawrence Erlbaum Associates Publishers; 1992. pp. 260–269.